Search Within

GENITOURINARY CANCERS

Cyclophosphamide and/or Anthracyclines Induced Epiphora in Breast Cancer Patients: A Rare Side-effect

Journal: Current Drug Safety
Volume: 13, Issue: 1
Page: 62-64
Authors: Ruchika Kalra, Bhavesh Chavada, Nishant R. Madhani, Bhargav Purohit* and C.B. Tripathi

A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 17, Issue: 4
Page: 276-284
Authors: Nur-Vaizura Mohamad, Ima-Nirwana Soelaiman and Kok-Yong Chin*

Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review

Journal: Current Cancer Drug Targets
Volume: 17, Issue: 7
Page: 603-616
Authors: Nishi Karunasinghe*, Jonathan Masters, Jack U. Flanagan and Lynnette R. Ferguson

Managing Expectations in the Transition to Proof of Concept Studies

Journal: Reviews on Recent Clinical Trials
Volume: 12, Issue: 2
Page: 111-123
Authors: Thomas Kieber-Emmons*, Issam Makhoul, Angela Pennisi, Eric R. Siegel, Peter D. Emanuel, Bejotaloh Monzavi-Karbassi, Zenon Steplewski, J. Thaddeus Beck and Laura F. Hutchins

Recent Advances in Drug Delivery of Polymeric Nano-Micelles

Journal: Current Drug Metabolism
Volume: 18, Issue: 1
Page: 16-29
Authors: Zarith Asyikin binti Abdul Aziz, Akil Ahmad, Siti Hamidah Mohd-Setapar, Hashim Hassan, David Lokhat, Mohammad Amjad Kamal and Ghulam Md. Ashraf

Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 22, Issue: 34
Page: 5234-5248
Authors: Kamlesh K. Yadav, Khader Shameer, Ben Readhead, Shalini S. Yadav, Li Li, Andrew Kasarskis, Ashutosh K. Tewari and Joel T. Dudley

NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization

Journal: Current Pharmaceutical Design
Volume: 22, Issue: 27
Page: 4173-4200
Authors: Javadi Monisha, Ganesan Padmavathi, Nand Kishor Roy, Anindita Deka, Devivasha Bordoloi, Anand Anip and Ajaikumar B. Kunnumakkara

Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11, Issue: 2
Page: 141-151
Authors: Xiao-Na Fang and Li-Wu Fu

Emerging Immunotargets in Bladder Cancer

Journal: Current Drug Targets
Volume: 17, Issue: 7
Page: 757-770
Authors: Francesco Massari, Chiara Ciccarese, Nuno Vau, Matteo Santoni, Rodolfo Montironi, Liang Cheng, Rita C. Marques, Marina Scarpelli, Jorge Fonseca, Marc R Matrana, Moch Holger, Stefano Cascinu, Giampaolo Tortora and Antonio Lopez-Beltran

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer

Journal: Current Drug Targets
Volume: 17, Issue: 3
Page: 276-289
Authors: Pavlos Msaouel, Jose Nahun Galeas, Alejandro Recio Boiles, Ramiro Rancier Ruiz and Michael Koutsilieris

Meet Our Editorial Board Member:

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16, Issue: 2
Page: 137-137
Authors: Jeanny B. Aragon-Ching

Recent Patents in Circulating Cell-Free Tumor DNA as Biomarker in Cancer

Journal: Recent Patents on Biomarkers (Discontinued)
Volume: 4, Issue: 3
Page: 150-162
Authors: Ines Prieto-Remon, Maria L. Antelo-Caamano, Jose J. Illarramendi-Manas and Angel G. Martin

Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis

Journal: Current Drug Targets
Volume: 16, Issue: 2
Page: 164-170
Authors: Roberto Iacovelli, Cora N. Sternberg, Camillo Porta, Elena Verzoni, Filippo de Braud, Bernard Escudier and Giuseppe Procopio

Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview

Journal: Current Drug Targets
Volume: 16, Issue: 2
Page: 96-102
Authors: Rodolfo Montironi, Matteo Santoni, Antonio Lopez-Beltran, Liang Cheng, Holger Moch and Marina Scarpelli

Oncotargets in Different Renal Cancer Subtypes

Journal: Current Drug Targets
Volume: 16, Issue: 2
Page: 125-135
Authors: Holger Moch, Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng and Axel Mischo

Editorial (Mini-Thematic Issue: Morphological and Molecular Backgrounds for Personalized Therapies in Genitourinary Cancers)

Journal: Current Drug Targets
Volume: 16, Issue: 2
Page: 94-95
Authors: Rodolfo Montironi, Marina Scarpelli, Matteo Santoni, Antonio Lopez-Beltran and Liang Cheng

MicroRNAs: A Novel Non-Invasive Biomarker for Patients with Urological Malignancies

Journal: Current Pharmaceutical Biotechnology
Volume: 15, Issue: 5
Page: 486-491
Authors: Jorg Ellinger and Stefan C. Muller


Prognostic and Predictive Biomarkers in Cancer

Journal: Current Cancer Drug Targets
Volume: 14, Issue: 5
Page: 477-504
Authors: Meera Nair, Sardul Singh Sandhu and Anil K. Sharma

Curcumin Potentiates The Ability of Sunitinib to Eliminate the VHL-lacking Renal Cancer Cells 786-O: Rapid Inhibition of Rb Phosphorylation as a Preamble to Cyclin D1 Inhibition

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13, Issue: 10
Page: 1508-1513
Authors: Priya Ranjan Debata, Sultana Begum, Anita Mata, Oksana Genzer, Morton J. Kleiner, Probal Banerjee and Mario R. Castellanos

Interactions of Iron Oxide Nanoparticles with the Immune System: Challenges and Opportunities for their Use in Nano-oncology

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 37
Page: 6606-6621
Authors: Dana C. Baiu, Christopher S. Brazel, Yuping Bao and Mario Otto

Targeting Metabolic Enzymes in Cancer – Clinical Trials Update

Journal: Current Enzyme Inhibition
Volume: 9, Issue: 2
Page: 152-160
Authors: Julie O’Neal and Jason Chesney

Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration

Journal: Current Cancer Drug Targets
Volume: 13, Issue: 4
Page: 444-459
Authors: Masaki Shiota, Akira Yokomizo, Naohiro Fujimoto, Hidetoshi Kuruma and Seiji Naito

From Bortezomib to other Inhibitors of the Proteasome and Beyond

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 22
Page: 4025-4038
Authors: Daniela Buac, Min Shen, Sara Schmitt, Fathima Rani Kona, Rahul Deshmukh, Zhen Zhang, Christine Neslund-Dudas, Bharati Mitra and Q. Ping Dou

Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13, Issue: 4
Page: 603-631
Authors: Karina Petit and Jean-Francois Biard

Synergistic Antiproliferative and Antiangiogenic Effects of EGFR and mTOR Inhibitors

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 5
Page: 918-926
Authors: L. Porcelli, A.E. Quatrale, P. Mantuano, N. Silvestris, J.F. Rolland, L. Biancolillo, A. Paradiso and A. Azzariti

High Performance Liquid Chromatographic Approaches to Mass Spectrometry Based Metabolomics

Journal: Current Metabolomics
Volume: 1, Issue: 1
Page: 58-83
Authors: Tong Zhang and David G. Watson

Prostate Cancer Immunotherapy: An Evolving Field

Journal: Current Cancer Therapy Reviews
Volume: 8, Issue: 4
Page: 274-282
Authors: Mehmood Hashmi, Dev Karan, Sneha Phadke, Yogen Saunthararajah, Suman Kambhampati and Peter Van Veldhuizen

A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma

Journal: Current Cancer Drug Targets
Volume: 12, Issue: 7
Page: 857-872
Authors: Z. Mihaly, Z. Sztupinszki, P. Surowiak and B. Gyorffy

Overcoming Drug Resistance and Treating Advanced Prostate Cancer

Journal: Current Drug Targets
Volume: 13, Issue: 10
Page: 1308-1323
Authors: Julius Semenas, Cinzia Allegrucci, Stephen A. Boorjian, Nigel P. Mongan and Jenny Liao Persson

Bladder Cancer: A Simple Model Becomes Complex

Journal: Current Genomics
Volume: 13, Issue: 5
Page: 395-415
Authors: Giovanni Battista Di Pierro, Caterina Gulia, Cristiano Cristini, Giorgio Fraietta, Lorenzo Marini, Pietro Grande, Vincenzo Gentile and Roberto Piergentili

Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer

Journal: Current Medicinal Chemistry
Volume: 19, Issue: 14
Page: 2061-2087
Authors: B. Orlikova and M. Diederich

Angiogenesis Inhibition in the Treatment of Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9, Issue: 10
Page: 1070-1078
Authors: Ravi A. Madan and William L. Dahut

Contemporary Role of Endocrine Treatment in Patients with Localized or Locally Advanced Prostate Cancer: A Review

Journal: Current Cancer Therapy Reviews
Volume: 7, Issue: 3
Page: 201-214
Authors: Vallejo Herrador J. and Martinez-Pineiro L.

Redistribution of CD95 into the Lipid Rafts to Treat Cancer Cells?

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5, Issue: 1
Page: 22-28
Authors: Bruno Segui and Patrick Legembre

VEGF Inhibitors and Prostate Cancer Therapy

Journal: Current Molecular Pharmacology
Volume: 2, Issue: 2
Page: 161-168
Authors: Jeanny B. Aragon-Ching and William L. Dahut

Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10, Issue: 3
Page: 225-235
Authors: J. Ansari, J. Glaholm, R. McMenemin, N.D. James and S.A. Hussain

VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 164-168
Authors: Toni K. Choueiri

Update on Hsp90 Inhibitors in Clinical Trial

Journal: Current Topics in Medicinal Chemistry
Volume: 9, Issue: 15
Page: 1479-1492
Authors: Y. S. Kim, S. V. Alarcon, S. Lee, M.-J. Lee, G. Giaccone, L. Neckers and J. B. Trepel

Subject Index to Volume 10

Journal: Current Pharmaceutical Design
Volume: 11, Issue: 1
Page: 101-142
Authors: Bentham Science Publishers

Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting

Journal: Current Cancer Drug Targets
Volume: 10, Issue: 1
Page: 46-54
Authors: D. Santini, V. Virzi, M. E. Fratto, F. Bertoldo, R. Sabbatini, R. Berardi, N. Calipari, D. Ottaviani and T. Ibrahim

Therapeutic Rationale for mTOR Inhibition in Advanced Renal Cell Carcinoma

Journal: Current Clinical Pharmacology
Volume: 6, Issue: 3
Page: 214-221
Authors: Holleh D. Husseinzadeh and Jorge A. Garcia

Magnetic Nanoparticles as Both Imaging Probes and Therapeutic Agents

Journal: Current Topics in Medicinal Chemistry
Volume: 10, Issue: 12
Page: 1184-1197
Authors: Lise-Marie Lacroix, Don Ho and Shouheng Sun

The Role of Protein Kinase C-alpha (PKC-α) in Cancer and its Modulation by the Novel PKC-α-Specific Inhibitor Aprinocarsen

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 16
Page: 1923-1936
Authors: A- R. Hanauske, Karen Sundell and Michael Lahn

Antisense Treatment in Human Prostate Cancer and Melanoma

Journal: Current Cancer Drug Targets
Volume: 10, Issue: 6
Page: 555-565
Authors: C. Di Cresce and J. Koropatnick

Overview of SLC22A and SLCO Families of Drug Uptake Transporters in the Context of Cancer Treatments

Journal: Current Drug Metabolism
Volume: 12, Issue: 8
Page: 793-807
Authors: Murray J. Cutler and Edna F. Choo

Macrocyclic Inhibitors of Hsp90

Journal: Current Topics in Medicinal Chemistry
Volume: 10, Issue: 14
Page: 1380-1402
Authors: Victoria A. Johnson, Erinprit K. Singh, Lidia A. Nazarova, Leslie D. Alexander and Shelli R. McAlpine

Erythropoietin in Cancer: An Update

Journal: Current Molecular Medicine
Volume: 8, Issue: 6
Page: 481-491
Authors: Jozsef Tovari, Robert Pirker, Jozsef Timar, Gyula Ostoros, Gabor Kovacs and Balazs Dome

DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening

Journal: Current Molecular Medicine
Volume: 10, Issue: 2
Page: 123-132
Authors: N. Shivapurkar and A. F. Gazdar

Editorial [ Hot Topic:Emerging Anticancer Effects of Antiresorptive Therapies (Guest Editor: Vera Hirsh)]

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12, Issue: 2
Page: 94-94
Authors: Vera Hirsh

New Therapeutic Strategies for Castration-Resistant Prostate Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6, Issue: 3
Page: 373-383
Authors: Tomoaki Tanaka and Tatsuya Nakatani

Protective Effect of NSAIDs on Cancer and Influence of COX-2 C G Genotype

Journal: Current Cancer Drug Targets
Volume: 8, Issue: 8
Page: 753-764
Authors: C. Siemes, L. E. Visser, J. W.W. Coebergh, A. Hofman, A. G. Uitterlinden and B.H. Ch. Stricker

Organ Preservation by the Association of Chemotherapy and Radiotherapy in Invasive Bladder Cancer

Journal: Current Drug Therapy
Volume: 5, Issue: 3
Page: 202-210
Authors: Marco Orsatti

Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12, Issue: 2
Page: 129-136
Authors: Fred Saad and Peter Mulders

Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity

Journal: Current Topics in Medicinal Chemistry
Volume: 11, Issue: 21
Page: 2602-2612
Authors: Chee Fei Chin, Daniel Yuan Qiang Wong, Ramasamy Jothibasu and Wee Han Ang

Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies

Journal: Current Drug Targets
Volume: 10, Issue: 10
Page: 982-1000
Authors: Vincenzo Emanuele Chiuri, Nicola Silvestris, Andrea Tinelli and Vito Lorusso

Gene Expression-Based Pharmacodynamic Biomarkers: The Beginning of a New Era in Biomarker-Driven Anti-Tumor Drug Development

Journal: Current Molecular Medicine
Volume: 10, Issue: 6
Page: 596-607
Authors: S. Mizuarai, H. Irie and H. Kotani

Curcumin and its Formulations: Potential Anti-Cancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12, Issue: 3
Page: 210-218
Authors: Jun-Ling Ji, Xian-Feng Huang and Hai-Liang Zhu

Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 7, Issue: 1
Page: 14-30
Authors: Erin R. King and Kwong-Kwok Wong

Current Perspectives in Prostate Cancer Vaccines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9, Issue: 10
Page: 1052-1057
Authors: Philip M. Arlen and James L. Gulley

Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11, Issue: 3
Page: 296-306
Authors: Jawaher Ansari, Syed A Hussain, Abdulla Alhasso, Rana Mahmood, Asif Ansari and John Glaholm

Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4, Issue: 2
Page: 146-156
Authors: Emmanuel Seront and Jean-Pascal Machiels

On the Nature of the Tumor-Initiating Cell

Journal: Current Stem Cell Research & Therapy
Volume: 7, Issue: 1
Page: 26-35
Authors: Eleazar Lara-Padilla and Julio Roberto Caceres-Cortes

The Potential of Flavonoids and Tannins from Medicinal Plants as Anticancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20
Page: 1-15
Authors: Eugenia D. Teodor*, Oana Ungureanu, Florentina Gatea and Gabriel L. Radu